Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Randomized Controlled Trial on the Effect of Gastric Bypass and Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients With BMI greater than 35 vs. Medical Therapy.

Next Previous
Trial Profile

Prospective Randomized Controlled Trial on the Effect of Gastric Bypass and Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients With BMI greater than 35 vs. Medical Therapy.

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antihyperglycaemics; Insulins
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DIBASY

Most Recent Events

  • 16 Sep 2019 Biomarkers information updated
  • 26 Mar 2012 Primary endpoint 'Remission-rate' has been met according to results published in the New England Journal of Medicine.
  • 26 Mar 2012 Results published in the New England Journal of Medicine.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top